Multi-stakeholder Interview: Get an Inside Look at the CDDF Multi-Stakeholder Discussion on Innovation and Access in Rare Cancers
The Cancer Drug Development Forum (CDDF) is delighted to share interview clips featuring a diverse group of stakeholders from our recent Multi-Stakeholder Workshop on Innovation and Access in Rare Cancers. Held in Amsterdam on 23-24 September 2024, the meeting...
Key Takeaways from the CDDF Live Webinar on EU Clinical Trial Regulations (Nov 2024)
🔔 📢 The Cancer Drug Development Forum (CDDF) held a live webinar on “EU Clinical Trial Regulations.” on 12 November at 17:00 CET. This webinar featured two lectures given by Dr Tarec Christoffer El-Galaly (Aahrus University, DK) and Stéphanie Kromar (EORTC, BE),...
Strengthened Collaboration between CDDF and Friends of Cancer Research
🔔We are excited to announce that CDDF and Friends of Cancer Research have formed a strengthened collaboration to accelerate innovative, effective cancer care for patients. By fostering multi-stakeholder collaboration across Europe and globally, we’re committed to...
![[Executive Summary: CDDF-EORTC Joint Workshop on Innovation and Access in Rare Cancers (23-24 September 2024, Amsterdam, NL)]](https://cddf.org/wp-content/uploads/2024/10/CDDF-EORTC-Workshop-on-Rare-Cancer_Sep2024_Executive-Summary_Image-1-400x250.jpg)
[Executive Summary: CDDF-EORTC Joint Workshop on Innovation and Access in Rare Cancers (23-24 September 2024, Amsterdam, NL)]
The Cancer Drug Development Forum (CDDF) is delighted to announce that the executive summary of its recent workshop on Rare Cancers has been published today and is available to all stakeholders. This collaborative initiative between CDDF and EORTC focused on...
CDDF Job Opening: Community & Communication Coordinator
The Cancer Drug Development Forum (CDDF) is seeking a talented Community & Communication Coordinator to be part of our dynamic team in Brussels. Join the CDDF team to contribute to a meaningful mission that accelerates the delivery of effective cancer treatments....
Key Takeaways from the CDDF-EORTC Workshop on Innovation and Access in Rare Cancers (23-24 Sep 2024, Amsterdam)
The first day of the CDDF workshop on Rare Cancers brought together a diverse group of stakeholders into open, constructive discussions in order to improve access to innovative therapies for patients with rare cancers. Here are the key takeaways from Day 1’s program:...
🔔 📢 Key Takeaways from the CDDF-ESMO Joint Session, “Regulatory Challenges in Clinical Cancer Drug Development” (16 Sep 2024)
The CDDF & ESMO educational session on "Regulatory Challenges in Clinical Cancer Drug Development" took place on 16 September 2024 at ESMO 2024. In this session, Aaron E. Sosa Mejia (Danish Medicines Agency) and Audrey Wolf (EFPIA) gave presentations followed by a...
![[🔔 📣 Call for pharmaceutical companies to join in the CDDF Diversity Initiative]](https://cddf.org/wp-content/uploads/2024/09/Copy-of-Copy-of-Copy-of-Dark-Purple-and-Blue-Texture-Blur-Circle-Business-Marketing-Presentation-400x250.jpg)
[🔔 📣 Call for pharmaceutical companies to join in the CDDF Diversity Initiative]
We are delighted to announce that the Cancer Drug Development Forum (CDDF) has launched its initiative on diversity in oncology clinical trials. CDDF cordially invites pharmaceutical companies to participate in this collaborative effort to support the planning and...
ACT EU: Stakeholder Presentation on Critical Use-Cases at MSP Advisory Group Meeting (4 July 2024)
On 4 July 2024, CDDF participated in a stakeholder presentation focused on critical use-cases at Multi-Stakeholder Platform (MSP) Advisory Group meeting. The session aimed to identify and discuss real-world challenges faced by stakeholder groups within the European...